| 1 |
34876673 | Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine. | 2022 Mar |
3 |
| 2 |
33938941 | Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia. | 2021 May 11 |
1 |
| 3 |
32547645 | Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategies. | 2020 |
2 |
| 4 |
32815024 | Favorable therapeutic response after anti-Mesothelin antibody-drug conjugate treatment requires high expression of Mesothelin in tumor cells. | 2020 Nov |
2 |
| 5 |
24714131 | Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect. | 2014 Jun |
2 |